Treatment/Management of PSP – Facebook Live, Mon., Dec. 5, 3pm PT

It looks like CurePSP has abandoned the webinar format and is opting for the Facebook Live format. The next event is as follows:

Monday, December 5, 3pm PT
Perhaps one hour in length
Speaker: Jori Fleisher, MD, movement disorder specialist, NYU Langone
Topic: Answering questions on treatment and management of PSP

If you are a Facebook member, you can access CurePSP Facebook page (unless they’ve fixed their permissions problems in which case non-Facebook members can access the CurePSP FB page) and leave a specific topic or question you’d like to suggest be addressed.

CurePSP indicates that “Dr. Fleisher specializes in treating patients with neurological disorders, and can address such issues as dealing with non-motor symptoms, palliative care vs hospice, and simple tips to manage daily activities.”

Unless CurePSP has fixed its permissions problems, only those who are Facebook members can access its Facebook page either live or to view the recorded version.

Here’s a link to CurePSP’s FB page:

www.facebook.com/curepsp.foundation

After the recorded version is posted, Brain Support Network will post the recorded version to the BSN Facebook page. We open our Facebook page to anyone, regardless of whether you are a Facebook member or not. Here’s a link to BSN’s FB page:

www.facebook.com/BrainSupportNetwork/

If the talk is worthwhile, I might post a transcript as I did with the last talk.

Robin

 

Dementia with Lewy Bodies in Today’s Caregiver

Caregiver.com’s enewsletter, Today’s Caregiver, has a feature today on Dementia with Lewy Bodies. I’ve copied parts of the article below.  Check out the link if you’d like to read the full article.

Robin

—————————-

us4.campaign-archive1.com/?u=3a9dceeae152c6cd205d8a038&id=7f8617b86d&e=aa5d316be5

Dementia with Lewy Bodies
Caregiver Thought Leader Interview: Scott Losk, PhD
Principal Investigator, Summit Research Network
by Gary Barg, Editor-in-Chief
Today’s Caregiver eNewsletter
December 2, 2016

Gary Barg: Let’s start at the beginning. What is dementia with Lewy bodies?

Dr. Scott Losk: Dementia with Lewy bodies happens to be the second most common cause of dementia affecting somewhere between a million and a million and a half people in the United States.

The symptoms are very different from Alzheimer’s disease though. I know that people get them confused, but the symptoms are different, especially the symptoms that we see early on in the course of the disease. Symptoms include visual hallucinations or seeing things that are not there. A large percentage of afflicted individuals experience REM sleep behavior disorder, so sleep is disrupted by thrashing around and sometimes really bad dreams. It is an impairment in the actual cycle of sleep.

Some of the other symptoms include variability in the level of alertness or arousal that a person may have. Cognitive symptoms include visual-spatial dysfunction, maybe some memory dysfunction and then what we call executive functioning impairment is often seen. This is a difficulty with mental tracking and organization and planning and those kinds of things.

The pathology in Lewy Body Disease are alpha-synuclein bodies that affect the brain in different places than the plaques and tangles we see in Alzheimer’s disease. Which is why we get the different symptom presentation.

Gary Barg: And it is harder than most dementias to diagnose from what I understand.

Dr. Scott Losk: If you are not aware of some of the early kinds of symptoms, you might miss it because you are looking for well, how bad the memory is or, how bad is one’s ability to learn new information? And frankly, a lot of my Lewy body patients are still able to learn fairly well. On memory testing they might actually perform at something close to the normal range and that is obviously very different than what we see in Alzheimer’s disease. So, if we see some of these symptoms I have described earlier, early in the course of the dementia, the evaluator (neurologist, geriatric psychiatrist, neuropsychologist, even primary care physician) needs to be thinking dementia with Lewy bodies (DLB). Then if we see any Parkinsonian symptoms in the individual, it is highly likely that DLB is going to be the more accurate diagnosis.

Gary Barg: We just had a conference in Tampa and a lot of the morning was taken up talking about Alzheimer’s and at lunch a lady said, “Please talk about Lewy body. It’s so much more difficult than just having a loved one live with Alzheimer’s because I’ve had both.”

Dr. Scott Losk:  I’ve got a couple of situations where mom has dementia and the caregiver’s sixty-five-year-old husband also has dementia. So both cases are unrelated. There is no heredity, there, but this person happens to be a caregiver for two people with Alzheimer’s or dementia. A horrible situation, but certainly, I think for caregivers, it is important to help the physician understand that the symptoms in each person are not the same. Because frankly, the patient with dementia with Lewy bodies may walk into the primary care doctor’s office and take that brief Mini Mental State Exam, or that MOCA, and perform nearly perfectly. Then the primary care doctor may say, “Oh, there is nothing wrong with you. You do fine on this brief memory test.” Well, the problem is that particular cognitive test does not measure what we need to be measuring in early onset dementia with Lewy bodies. We need a robust assessment of executive function, of visual special function and then a robust history that tells us more about the sleep disturbance and the hallucinations and about Parkinson’s type symptoms. So it can be difficult to diagnose, but in the hands of a skilled evaluator, this differential can be made relatively easily.

Gary Barg: And Lewy bodies came into the public eye two years ago when Robin Williams had experience with the disease. Tell me some of your thoughts about his story.

Dr. Scott Losk: Yes, it is a horribly sad story. I’m convinced that one of the cognitive attributes that makes a person brilliantly funny is to be able to tell a story, or to tell a joke, and then at the very end, the path where your brain is going, is not where his brain goes, and it ends up being this disconnect that happens to be hilarious. And he had an incredible gift for being able to do that. He had what I would call extremely advanced frontal lobes. The frontal lobes are responsible for being able to reflect on one’s own condition, being able to plan for the future and being able to empathize with other people. It is also that gut level intuition that comes from the frontal lobes. So he was acutely aware of his brain changing at the hands of dementia with Lewy bodies.

Gary Barg: Would you have any specific advice for DLB family caregivers?

Dr. Scott Losk: Yeah, I actually do. One, is if there is still a lack of clarity as to what your loved one’s condition is, first and foremost spouses and caregivers, adult children, really need to be assertive about getting the necessary evaluations done, or referrals to specialists. In this particular case it is neurology, geriatric psychiatry or get them into the hands of a competent neuropsychologist who can do a detailed evaluation.

As a family caregiver, it is of critical importance to not allow your loved one’s disease to completely and totally own you. I mean, it is going to have a huge impact, there is no way around that, but maintaining some of the interests, activities, socialization and involvement for the caregiver in their regular routine, is crucial. And hopefully being able to have one or two or three friends and loved ones that they can share some of their burdens with, and some of their experiences with, and so forth.

The other piece is just to continue to get better and better educated. …

Scott Losk, PhD, obtained a doctorate at Fuller Graduate School of Psychology in 1989, and did a post-doctoral fellowship in medical psychology at Oregon Health Sciences University. He has been in private practice since 1990, with an emphasis on clinical psychology, neuropsychology, and geriatric psychology. Dr. Losk joined Summit Research Network, formerly Pacific Northwest Clinical Research Center in 1990. He has been an investigator in over 100 clinical trials evaluating treatments of disorders of the central nervous system, and the principal investigator in over 75 clinical trials evaluating treatments for Alzheimer’s disease. Dr. Losk is currently conducting a clinical trial for dementia with Lewy bodies, which is the second most common cause of dementia after Alzheimer’s disease.